Home > Income Statement > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Revenue

    Back to Income Statement
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹336 Cr₹279 Cr₹231 Cr₹46 Cr₹1,360 Cr

What is the latest Revenue of BALAXI PHARMACEUTICALS ?

The latest Revenue ratio of BALAXI PHARMACEUTICALS is ₹336 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹336 Cr
Mar2023₹279 Cr
Mar2022₹231 Cr
Mar2021₹46 Cr
Mar2020₹1,360 Cr

How is Revenue of BALAXI PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2024 ₹336 Cr
20.42
Mar2023 ₹279 Cr
20.77
Mar2022 ₹231 Cr
406.94
Mar2021 ₹46 Cr
-96.64
Mar2020 ₹1,360 Cr -

Compare Revenue of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹270.4 Cr 0% -7.4% -56.4% Stock Analytics
ADANI ENTERPRISES ₹295,742.0 Cr -0.4% 0.8% -17% Stock Analytics
REDINGTON ₹23,433.7 Cr -3.3% 0.1% 43.3% Stock Analytics
LLOYDS ENTERPRISES ₹11,531.8 Cr 1.1% 24.6% 141.3% Stock Analytics
MMTC ₹10,198.5 Cr -2.4% -4.7% -18.5% Stock Analytics
HONASA CONSUMER ₹9,573.4 Cr -0.7% -5.6% -33.7% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

0%

-7.4%

-56.4%

SENSEX

-1.1%

-0%

3.2%


You may also like the below Video Courses